CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.8B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.45: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.80BUSDvs all stocks (USD)
Trailing P/E
20.95xRevenue (TTM)
923.71MUSDvs all stocks (USD)
Profit Margin
9.98%Beta
0.4320xvs all stocks
52-Week Change
21.08%vs all stocks
Market Capitalization
1.80BUSDvs all stocks (USD)
Enterprise Value
2.02BUSDvs all stocks (USD)
Trailing P/E
20.95xForward P/E
7.59xPEG Ratio
0.2404xPrice to Sales (TTM)
2.02xPrice to Book (MRQ)
3.11xEnterprise to Revenue
2.19xEnterprise to EBITDA
10.22xGross Margin
60.59%Profit Margin
9.98%Operating Margin
16.30%Return on Assets (TTM)
4.97%Return on Equity (TTM)
18.32%Revenue (TTM)
923.71MUSDvs all stocks (USD)
Revenue per Share (TTM)
45.33USDUpdated Jul 18, 2026Quarterly Revenue Growth
20.50%Gross Profit (TTM)
561.85MUSDvs all stocks (USD)
EBITDA (TTM)
196.36MUSDvs all stocks (USD)
Net Income (TTM)
83.94MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
88.10%Operating Cash Flow (TTM)
208.61MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
140.26MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
883.37MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
341.31MUSDFY2025 · Dec 31, 2025Gross Profit
542.06MUSDFY2025 · Dec 31, 2025Operating Income
81.23MUSDvs all stocks (USD)
Pre-tax Income
95.79MUSDFY2025 · Dec 31, 2025Income Tax Expense
17.45MUSDFY2025 · Dec 31, 2025Net Income
78.34MUSDFY2025 · Dec 31, 2025EBIT
115.85MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
174.58MUSDFY2025 · Dec 31, 2025Research & Development
51.66MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
317.75MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
20.06MUSDFY2025 · Dec 31, 2025EPS (Basic)
3.50USDFY2025 · Dec 31, 2025EPS (Diluted)
3.32USDFY2025 · Dec 31, 2025Basic Shares Outstanding
20.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
78.34MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
6.96MUSDFY2025 · Dec 31, 2025Operating Cash Flow
139.39MUSDFY2025 · Dec 31, 2025Free Cash Flow
125.55MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
285.62MUSDFY2025 · Dec 31, 2025Income Tax Paid
17.67MUSDFY2025 · Dec 31, 2025Interest Paid
26.93MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
78.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
91.42MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
14.24MUSDFY2025 · Dec 31, 2025Stock-based Compensation
37.93MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-27.90MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-58.53MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
15.16MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.26MUSDFY2025 · Dec 31, 2025Capital Expenditures
-13.84MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-20.49MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-13.84MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-10.16MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-12.21MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-1.16MUSDFY2025 · Dec 31, 2025Other Financing Charges
-26.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-23.55MUSDFY2025 · Dec 31, 2025Shares Outstanding
22.88MSharesUpdated Jul 18, 2026Float Shares
19.42MSharesUpdated Jul 18, 2026Shares Short
3.44MSharesUpdated Jul 18, 2026Short Ratio
10.37daysvs all stocks
Short % of Shares Outstanding
18.48%vs all stocks
% Held by Insiders
5.54%vs all stocks
% Held by Institutions
110.36%vs all stocks
Total Cash (MRQ)
326.06MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
15.38USDUpdated Jul 18, 2026Total Debt (MRQ)
630.21MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.12xCurrent Ratio (MRQ)
3.12xBook Value per Share (MRQ)
26.34USDUpdated Jul 18, 2026Total Assets
1.44BUSDvs all stocks (USD)
Total Current Assets
753.12MUSDFY2025 · Dec 31, 2025Total Liabilities
899.65MUSDFY2025 · Dec 31, 2025Total Non-current Assets
687.26MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
621.54MUSDFY2025 · Dec 31, 2025Total Current Liabilities
278.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
285.58MUSDFY2025 · Dec 31, 2025Other Short-term Investments
9.13MUSDFY2025 · Dec 31, 2025Accounts Receivable
281.08MUSDFY2025 · Dec 31, 2025Inventory
143.07MUSDFY2025 · Dec 31, 2025Accounts Payable
62.58MUSDFY2025 · Dec 31, 2025Short-term Debt
17.27MUSDFY2025 · Dec 31, 2025Other Current Liabilities
167.00KUSDFY2025 · Dec 31, 2025Long-term Debt
599.77MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
21.77MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-23.10MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
540.72MUSDvs all stocks (USD)
Treasury Stock
33.25MUSDFY2025 · Dec 31, 202552-Week Low
62.61USDUpdated Jul 18, 202652-Week High
99.50USDUpdated Jul 18, 202652-Week Change
21.08%vs all stocks
Beta
0.4320xvs all stocks
50-Day MA
81.52USDUpdated Jul 18, 2026200-Day MA
81.93USDUpdated Jul 18, 2026Avg 10-Day Volume
285.19KSharesUpdated Jul 18, 2026Avg 30-Day Volume
312.88KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
3.91USDUpdated Jul 18, 2026Other Income / Expense
34.62MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.45: grey zoneSignificant
Altman Z-Score: 2.45
High earnings qualityNotable
Earnings Quality Score: 0.94
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.8B, above the global median of $1.15BNotable
Market cap (USD): 1,800,581,745Global Median: 1,146,734,693.424
Revenue is $923.71M, above the global median of $520.53MNotable
Revenue (USD): 923,705,984Global Median: 520,528,949.311
Levered free cash flow is $140.26M, above the global median of $16.24MNotable
Levered free cash flow (USD): 140,259,504Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Bausch Health Companies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Stoke Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
PolyPeptide Group AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
BeBetter Med Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chengdu Olymvax Biopharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sarepta Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zymeworks Inc.
Tier 1ProductionApproval-Gated PipelineRule
Heron Neutron Medical Corp.
Tier 1ProductionApproval-Gated PipelineRule
Bicara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
D&D Pharmatech Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk